A journey into the regulatory secrets of the de novo purine nucleotide biosynthesis
De novo purine nucleotide biosynthesis (DNPNB) consists of sequential reactions that are majorly conserved in living organisms. Several regulation events take place to maintain physiological concentrations of adenylate and guanylate nucleotides in cells and to fine-tune the production of purine nucl...
Main Authors: | Nour Ayoub, Antoine Gedeon, Hélène Munier-Lehmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1329011/full |
Similar Items
-
Inosine monophosphate dehydrogenase : a major therapeutic target /
by: Pankiewicz, Krzysztof W., 1942-, et al.
Published: (2003) -
Biosynthesis and Transport of Nucleotide Sugars for Plant Hemicellulose
by: Wenjuan Zhang, et al.
Published: (2021-11-01) -
Disruption of de novo purine biosynthesis in Pseudomonas fluorescens Pf0-1 leads to reduced biofilm formation and a reduction in cell size of surface-attached but not planktonic cells
by: Shiro Yoshioka, et al.
Published: (2016-01-01) -
Effects of purine nucleotide administration on purine nucleotide metabolism in brains of heroin-dependent rats
by: Kun Li, et al. -
Identification of USP29 as a key regulator of nucleotide biosynthesis in neuroblastoma through integrative analysis of multi-omics data
by: Ye Kang, et al.
Published: (2023-12-01)